Grace Therapeutics, Inc.
GRCE
$2.07+0.24%
End of day · as of Oct 7, 2026, 6:15 AM ET
Mkt cap
$34.98M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2026)
N/A
EPS (9mo ended 2025-12-31)
$-0.41
Gross Margin (FY2026)
N/A
Profit Margin (FY2026)
N/A
Beta
1.37
Div yield
N/A
Sector
Healthcare
Grace Therapeutics, Inc. (GRCE) is a biotechnology company listed on US.
Use this GRCE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GRCE income, balance, and cash tables.
Grace Therapeutics, Inc. (GRCE) is a biotechnology company in the Healthcare sector.
Latest cached Grace Therapeutics, Inc. (GRCE) net income for FY2026 was -$7.8M. Statements: https://lician.com/financials/grce
Grace Therapeutics, Inc. (GRCE) market capitalization is $35.0M on the latest cached snapshot.
Grace Therapeutics, Inc. (GRCE) cached previous close $2.06; day range $2.05 – $2.14; volume 110,217. Session quote: https://lician.com/quote/grce
Grace Therapeutics, Inc. (GRCE) latest cached earnings event is "GRCE earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached GRCE filing is 8-K · Sep 18, 2026. Filings: https://lician.com/sec/grce